Fairmount Funds Management LLC - Director, 10%+ Owner at Oruka Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
ORKA, ABIO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Fairmount Funds Management LLC since 11/5/2023

Holdings reported by Fairmount Funds Management LLC for Oruka Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.57M $59.2M $23.00 Sep 11, 2024 By Fairmount Healthcare Co-Invest III L.P.
Common Stock 639K $14.7M $23.00 Sep 11, 2024 By Fairmount Healthcare Fund II L.P.
Series A Non-Voting Convertible Preferred Stock 160 $3.68M $23,000.00 Sep 11, 2024 By Fairmount Healthcare Fund II L.P. Common Stock

Transactions reported by Fairmount Funds Management LLC for Oruka Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.